References 1. Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH: Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 2005,97(13):966–975.PubMedCentralPubMedCrossRef 2. Dawood S, Merajver SD, Viens P, Vermeulen PB, Swain SM, Idasanutlin supplier Buchholz TA, Dirix LY, Levine PH, Lucci A, Krishnamurthy S, Robertson FM, Woodward WA, Yang WT, Ueno NT, Cristofanilli M: International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and

treatment. Ann Oncol 2011,22(3):515–523.PubMedCentralPubMedCrossRef 3. Jaiyesimi IA, Buzdar AU, Hortobagyi G: Inflammatory breast cancer: a review. J Clin Oncol 1992,10(6):1014–1024.PubMed see more 4. Cristofanilli M, Valero V, Buzdar AU, Kau SW, Broglio KR, Gonzalez-Angulo AM, Sneige N, Islam R, Ueno NT, Buchholz buy Sapanisertib TA, Singletary SE, Hortobagyi GN: Inflammatory breast cancer (IBC) and patterns

of recurrence: understanding the biology of a unique disease. Cancer 2007,110(7):1436–1444.PubMedCrossRef 5. Robertson FM, Bondy M, Yang W, Yamauchi H, Wiggins S, Kamrudin S, Krishnamurthy S, Le-Petross H, Bidaut L, Player AN, Barsky SH, Woodward WA, Buchholz T, Lucci A, Ueno NT, Cristofanilli M: Inflammatory breast cancer: the disease, the biology, the treatment. CA Cancer J Clin 2010,60(6):352–375.CrossRef 6. Dawood S, Cristofanilli M: Inflammatory Protirelin breast cancer: what progress have we made? Oncology 2011,25(3):264–270.PubMed 7. Cabioglu N, Gong Y, Islam R, Broglio KR, Sneige N, Gonzalez-Angulo AM, Morandi P, Bucana C, Hortobagyi GN, Cristofanilli

M: Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. Ann Oncol 2007,18(6):1021–1029.PubMedCrossRef 8. Masuda H, Zhang D, Bartholomeusz C, Doihara H, Hortobagyi GN, Ueno NT: Role of epidermal growth factor receptor in breast cancer. Breast Cancer Res Treat 2012.,136(2): doi:10.1007/s10549–012–2289–9 doi:10.1007/s10549-012-2289-9 9. Yamauchi H, Cristofanilli M, Nakamura S, Hortobagyi GN, Ueno NT: Molecular targets for treatment of inflammatory breast cancer. Nat Rev Clin Oncol 2009,6(7):387–394.PubMedCrossRef 10. Van Laere SJ, Van den Eynden GG, Van der Auwera I, Vandenberghe M, van Dam P, Van Marck EA, van Golen KL, Vermeulen PB, Dirix LY: Identification of cell-of-origin breast tumor subtypes in inflammatory breast cancer by gene expression profiling. Breast Cancer Res Treat 2006,95(3):243–255.PubMedCrossRef 11. Zell JA, Tsang WY, Taylor TH, Mehta RS, Anton-Culver H: Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry. Breast Cancer Res 2009,11(1):R9. doi:10.1186/bcr2225CrossRefPubMedCentralPubMed 12.